Ashvattha Therapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Jeffrey Cleland, Ph.D., chairman, chief executive officer and president of Ashvattha Therapeutics, will present at the virtual H.C. Wainwright 22nd Annual Global Investment Conference on Monday, September 14, 2020.